Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country

DB Vale, MT Silva, MG Discacciati, I Polegatto… - Plos one, 2021 - journals.plos.org
Objective To report a modelling study using local health care costs and epidemiological
inputs from a population-based program to access the cost-effectiveness of adopting hrHPV …

Point-of-care molecular test for the detection of 14 high-risk genotypes of human papillomavirus in a single tube

S Seely, JM Zingg, P Joshi, B Slomovitz… - Analytical …, 2023 - ACS Publications
Cervical cancers constitute a large disease burden in developing countries, with the human
papillomavirus (HPV) being responsible for most cervical lesions. Many regions in low …

Comparison of HPV testing and colposcopy in detecting cervical dysplasia in patients with cytological abnormalities

J Świderska-Kiec, K Czajkowski, J Zaręba-Szczudlik… - in vivo, 2020 - iv.iiarjournals.org
Aim: The aim of the study was to compare the diagnostic value of HPV testing and
colposcopy in patients with abnormal cytology results. Patients and Methods: A total of 186 …

Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis

D Figueiredo, I Ribeiro, A Penedones, D Mendes… - BMC women's …, 2023 - Springer
Background Cervical cancer is a major concern to women's health, being the fourth most
common cancer worldwide. A great percentage of these cancer is consequence of an HPV …

Secondary prevention and treatment of cervical cancer–an update from Poland

P Poniewierza, M Śniadecki… - … Journal of Oncology, 2022 - journals.viamedica.pl
Introduction. Cervical cancer is the 4th most common cancer in terms of incidence and
mortality in women worldwide. The aim of the study was to investigate and analyze the …

Addressing Cervical Cancer Screening Through Self-Sampling and HPV Testing Among Under-Screened Women: A Case Study in the Decentralized Portuguese …

SG Pereira, L Nobre, M Ribeiro, P Carvalho, A Morais… - medRxiv, 2024 - medrxiv.org
Background: Cervical cancer (CC) screening is crucial for reducing its incidence. However,
encouraging participation among under-screened women remains challenging. Portugal's …

A systematic review of economic evaluations of cervical cancer screening methods

T Sefuthi, L Nkonki - Systematic Reviews, 2022 - Springer
Objective The aims of this systematic review were to (1) identify primary-and model-based
economic evaluations of cervical cancer screening methods and to (2) provide a contextual …

[HTML][HTML] Cost-Effectiveness and Budget Impact Analysis of Primary Screening With Human Papillomavirus Test With Genotyping in Argentina

OU Garay, JM Furcada, F Ayerbe, RAPR Rave… - Value in Health …, 2021 - Elsevier
Objectives Cervical cancer (ICC) is the fourth leading cause of mortality in women in
Argentina and primary screening with conventional cytology (Papanicolaou smear) is the …

Virus del papiloma humano y su asociación con el cáncer cervicouterino: una perspectiva mundial

AAZ Cedeño, YSP Cobeña, SA Díaz… - Revista Científica Higía …, 2023 - itsup.edu.ec
El virus del papiloma humano se encuentra estrechamente asociado con el cáncer
cervicouterino, de los más de 100 virus del papiloma humano, 40 son contagiados …

Anormalidades en citologías cervicovaginales de mujeres de la Unidad de Medicina Familiar No. 3 de Ciudad Valles, SLP

MP Galarza Ortega - REPOSITORIO NACIONAL …, 2024 - repositorioinstitucional.uaslp.mx
Se ha determinado que en México, la tasa estandarizada de Cáncer cervical es de 19.2 x
100, 000 mujeres. Las infecciones constituyen el factor de riesgo para esta entidad. Se ha …